Pliant Therapeutics
PLRX
PLRX
110 hedge funds and large institutions have $925M invested in Pliant Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
100% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 19
25% more funds holding
Funds holding: 88 → 110 (+22)
9.92% more ownership
Funds ownership: 83.32% → 93.23% (+9.9%)
Holders
110
Holding in Top 10
8
Calls
$4.22M
Puts
$1.71M
Top Buyers
| 1 | +$57.3M | |
| 2 | +$41.4M | |
| 3 | +$36.4M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$30.1M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$29.2M |
Top Sellers
| 1 | -$41.8M | |
| 2 | -$20.2M | |
| 3 | -$9.8M | |
| 4 |
Goldman Sachs
New York
|
-$6.87M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.26M |